{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:51:38Z","timestamp":1794365498866,"version":"4.9.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s10552-006-0033-7","type":"journal-article","created":{"date-parts":[[2006,7,14]],"date-time":"2006-07-14T04:49:15Z","timestamp":1152852555000},"page":"871-888","source":"Crossref","is-referenced-by-count":86,"title":["Aspirin and cancer risk: an updated quantitative review to 2005"],"prefix":"10.1007","volume":"17","author":[{"given":"Cristina","family":"Bosetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Gallus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"33_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/oxfordjournals.epirev.a017926","volume":"18","author":"HJ Berkel","year":"1996","unstructured":"Berkel HJ, Holcombe RF, Middlebrooks M, Kannan K (1996) Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev 18:205\u2013217","journal-title":"Epidemiol Rev"},{"key":"33_CR2","unstructured":"Greenberg ER, Baron JA (1996) Aspirin and other nonsteroidal anti-inflammatory drugs as cancer-preventive agents. In: Stewart BW, McGregor D, Kleihies P (eds) Principles of chemoprevention. IARC Scientific Publications No. 139. International Agency for Research on Cancer, Lyon"},{"key":"33_CR3","volume-title":"Non-steroidal anti-inflammatory drugs","author":"IARC Handbooks of Cancer Prevention","year":"1997","unstructured":"IARC Handbooks of Cancer Prevention (1997) Non-steroidal anti-inflammatory drugs, vol 1. International Agency for Research on Cancer, Lyon"},{"key":"33_CR4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","volume":"90","author":"MM Taketo","year":"1998","unstructured":"Taketo MM (1998) Cyclooxygenase-2 inhibitors in cancerogenesis (Part I). J Natl Cancer Inst 90:1529\u20131536","journal-title":"J Natl Cancer Inst"},{"key":"33_CR5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jnci\/90.21.1609","volume":"90","author":"MM Taketo","year":"1998","unstructured":"Taketo MM (1998) Cyclooxygenase-2 inhibitors in cancerogenesis (Part II). J Natl Cancer Inst 90:1609\u20131620","journal-title":"J Natl Cancer Inst"},{"key":"33_CR6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1590-8658(01)80152-3","volume":"33","author":"S Fiorucci","year":"2001","unstructured":"Fiorucci S, Antonelli E (2001) Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by inflammatory agents. Digest Liver Dis 33:S2\u2013S7","journal-title":"Digest Liver Dis"},{"key":"33_CR7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252\u2013266","journal-title":"J Natl Cancer Inst"},{"key":"33_CR8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008469-200212000-00005","volume":"11","author":"C Bosetti","year":"2002","unstructured":"Bosetti C, Gallus S, La Vecchia C (2002) Aspirin and cancer risk: an update to 2001. Eur J Cancer Prev 11:535\u2013542","journal-title":"Eur J Cancer Prev"},{"key":"33_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","volume":"3","author":"A Gonz\u00e1lez P\u00e9rez","year":"2003","unstructured":"Gonz\u00e1lez P\u00e9rez A, Garc\u00eda Rodr\u00edguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 3:28","journal-title":"BMC Cancer"},{"key":"33_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","volume":"9","author":"S Greenland","year":"1987","unstructured":"Greenland S (1987) Quantitative methods in the review of epidemiological literature. Epidemiol Rev 9:1\u201330","journal-title":"Epidemiol Rev"},{"key":"33_CR11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0021-9681(78)90071-1","volume":"31","author":"HA Isom\u00e4ki","year":"1978","unstructured":"Isom\u00e4ki HA, Hakulinen T, Joutsenlahti U (1978) Excess of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J Chron Dis 31:691\u2013696","journal-title":"J Chron Dis"},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","volume":"85","author":"G Gridley","year":"1993","unstructured":"Gridley G, McLaughlin JK, Ekbom A, et al (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307\u2013311","journal-title":"J Natl Cancer Inst"},{"key":"33_CR13","first-page":"551","volume":"14","author":"M Kauppi","year":"1996","unstructured":"Kauppi M, Pukkala E, Isom\u00e4ki H (1996) Low incidence of colorectal cancer in patients with rheumatoid arthritis. Clin Exp Rheumatol 14:551\u2013553","journal-title":"Clin Exp Rheumatol"},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjc.6600760","volume":"88","author":"S Friis","year":"2003","unstructured":"Friis S, Sorensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH (2003) A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 88:684\u2013688","journal-title":"Br J Cancer"},{"key":"33_CR15","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1345\/aph.1C489","volume":"37","author":"JM Herendeen","year":"2003","unstructured":"Herendeen JM, Lindley C (2003) Use of NSAIDs for the chemoprevention of colorectal cancer. Ann Pharmacother 37:1664\u20131674","journal-title":"Ann Pharmacother"},{"key":"33_CR16","first-page":"4399","volume":"48","author":"GA Kune","year":"1988","unstructured":"Kune GA, Kune S, Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case\u2013control results from the Melbourne colorectal cancer study. Cancer Res 48:4399\u20134404","journal-title":"Cancer Res"},{"key":"33_CR37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jnci\/83.5.355","volume":"83","author":"L Rosenberg","year":"1991","unstructured":"Rosenberg L, Palmer JR, Zauer AG, et al (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355\u2013358","journal-title":"J Natl Cancer Inst"},{"key":"33_CR18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D","volume":"72","author":"O Suh","year":"1993","unstructured":"Suh O, Mettlin C, Petrelli NJ (1993) Aspirin use, cancer, and polyps of the large bowel. Cancer 72:1171\u20131177","journal-title":"Cancer"},{"key":"33_CR19","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#","volume":"74","author":"JE Muscat","year":"1994","unstructured":"Muscat JE, Stellman SD, Wynder EL (1994) Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 74:1847\u20131854","journal-title":"Cancer"},{"key":"33_CR20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archinte.1994.00420040050009","volume":"154","author":"II Peleg","year":"1994","unstructured":"Peleg II, Maibach HT, Brown SH, Wilcox CM (1994) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154:394\u2013399","journal-title":"Arch Intern Med"},{"key":"33_CR21","first-page":"955","volume":"5","author":"MJ Reeves","year":"1996","unstructured":"Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL (1996) Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 5:955\u2013960","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/bjc.1997.444","volume":"76","author":"C La Vecchia","year":"1997","unstructured":"La Vecchia C, Negri E, Franceschi S, et al (1997) Aspirin and colorectal cancer. Br J Cancer 76:675\u2013677","journal-title":"Br J Cancer"},{"key":"33_CR23","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q","volume":"82","author":"L Rosenberg","year":"1998","unstructured":"Rosenberg L, Louik C, Shapiro S (1998) Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer 82:2326\u20132333","journal-title":"Cancer"},{"key":"33_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1099-1557(199803\/04)7:2<99::AID-PDS320>3.0.CO;2-0","volume":"7","author":"GD Friedman","year":"1998","unstructured":"Friedman GD, Coates AO, Potter JD, Slattery ML (1998) Drugs and colon cancer. Pharmacoepidemiol Drug Saf 7:99\u2013106","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"33_CR25","first-page":"869","volume":"7","author":"AI Neugut","year":"1998","unstructured":"Neugut AI, Rosenberg DJ, Ahsan H, et al (1998) Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 7:869\u2013873","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00008469-200210000-00009","volume":"11","author":"M Juarranz","year":"2002","unstructured":"Juarranz M, Calle-Pur\u00f3n ME, Gonz\u00e1lez-Navarro A, et al (2002) Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer. Eur J Cancer Prev 11:465\u2013472","journal-title":"Eur J Cancer Prev"},{"key":"33_CR27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/aje\/kwi248","volume":"162","author":"LB Sansbury","year":"2005","unstructured":"Sansbury LB, Millikan RC, Schroeder JC, Moorman PG, North KE, Sandler RS (2005) Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case\u2013control study of African Americans and Whites. Am J Epidemiol 162:548\u2013558","journal-title":"Am J Epidemiol"},{"key":"33_CR28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/bmj.299.6710.1247","volume":"299","author":"A Paganini-Hill","year":"1989","unstructured":"Paganini-Hill A, Chao A, Ross RK, Henderson BE (1989) Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 299:1247\u20131250","journal-title":"Br Med J"},{"key":"33_CR29","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","volume":"325","author":"MJ Thun","year":"1991","unstructured":"Thun MJ, Namboodiri MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593\u20131596","journal-title":"N Engl J Med"},{"key":"33_CR17","first-page":"1322","volume":"53","author":"MJ Thun","year":"1993","unstructured":"Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322\u20131327","journal-title":"Cancer Res"},{"key":"33_CR30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","volume":"5","author":"DM Schreinemachers","year":"1994","unstructured":"Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5:138\u2013146","journal-title":"Epidemiology"},{"key":"33_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-121-4-199408150-00001","volume":"121","author":"E Giovannucci","year":"1994","unstructured":"Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Int Med 121:241\u2013246","journal-title":"Ann Int Med"},{"key":"33_CR32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","volume":"333","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Egan KM, Hunter DJ, et al (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333:609\u2013614","journal-title":"N Engl J Med"},{"key":"33_CR33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001648-200101000-00015","volume":"12","author":"LA Garc\u00eda-Rodr\u00edguez","year":"2001","unstructured":"Garc\u00eda-Rodr\u00edguez LA, Huerta-Alvarez C (2001) Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 12:88\u201393","journal-title":"Epidemiology"},{"key":"33_CR34","first-page":"3177","volume":"24","author":"LD Ratnasinghe","year":"2004","unstructured":"Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E (2004) Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 24:3177\u20133184","journal-title":"Anticancer Res"},{"key":"33_CR35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.294.8.914","volume":"294","author":"AT Chan","year":"2005","unstructured":"Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS (2005) Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294:914\u2013923","journal-title":"JAMA"},{"key":"33_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.20097","volume":"110","author":"F Levi","year":"2004","unstructured":"Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2004) Cancer mortality in Europe, 1995\u20131999, and an overview of trends since 1960. Int J Cancer 110:155\u2013169","journal-title":"Int J Cancer"},{"key":"33_CR38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10350-003-0111-9","volume":"47","author":"TK Asano","year":"2004","unstructured":"Asano TK, McLeod RS (2004) Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review. Dis Colon Rectum 47:665\u2013673","journal-title":"Dis Colon Rectum"},{"key":"33_CR39","doi-asserted-by":"crossref","unstructured":"Greenberg ER, Baron JA, Freeman DH Jr, Mandet JS, Haile R, for the Polyp Prevention Study Group (1993) Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 85:912\u2013916","DOI":"10.1093\/jnci\/85.11.912"},{"key":"33_CR40","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","volume":"348","author":"RS Sandler","year":"2003","unstructured":"Sandler RS, Halabi S, Baron JA, et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883\u2013890","journal-title":"N Engl J Med"},{"key":"33_CR41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron JA, Cole BF, Sandler RS, Haile RW, et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891\u2013899","journal-title":"N Engl J Med"},{"key":"33_CR42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","volume":"125","author":"R Benamouzig","year":"2003","unstructured":"Benamouzig R, Deyra J, Martin A, et al (2003) Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125:328\u2013336","journal-title":"Gastroenterology"},{"key":"33_CR43","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jnci\/85.15.1220","volume":"85","author":"PH Gann","year":"1993","unstructured":"Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH (1993) Low-dose aspirin and incidence of colorectal cancers in a randomized trial. J Natl Cancer Inst 85:1220\u20131224","journal-title":"J Natl Cancer Inst"},{"key":"33_CR44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-128-9-199805010-00003","volume":"128","author":"T St\u00fcrmer","year":"1998","unstructured":"St\u00fcrmer T, Glynn RJ, Lee I-M, Manson JE, Buring JE, Hennekens CH (1998) Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians\u2019 Health Study. Ann Intern Med 128:713\u2013720","journal-title":"Ann Intern Med"},{"key":"33_CR45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM, et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women\u2019s Health Study: a randomized controlled trial. JAMA 294:47\u201355","journal-title":"JAMA"},{"key":"33_CR46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","volume":"321","author":"S Derry","year":"2000","unstructured":"Derry S, Loke YK (2000) Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 321:1183\u20131187","journal-title":"BMJ"},{"key":"33_CR58","first-page":"97","volume":"7","author":"DC Farrow","year":"1998","unstructured":"Farrow DC, Vaughan TL, Hansten PD, et al (1998) Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 7:97\u2013102","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR48","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1054\/bjoc.2001.2147","volume":"85","author":"L Sharp","year":"2001","unstructured":"Sharp L, Chilvers CE, Cheng KK, et al (2001) Risk factors for squamous cell carcinoma of the esophagus in women: a case\u2013control study. Br J Cancer 85:1667\u20131670","journal-title":"Br J Cancer"},{"key":"33_CR49","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","volume":"76","author":"EM Funkhouser","year":"1995","unstructured":"Funkhouser EM, Sharp GB (1995) Aspirin and reduced risk of esophageal carcinoma. Cancer 76:1116\u20131119","journal-title":"Cancer"},{"key":"33_CR50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1055-9965.EPI-04-0467","volume":"14","author":"M Lindblad","year":"2005","unstructured":"Lindblad M, Lagergren J, Garc\u00eda Rodr\u00edguez LA (2005) Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 14:444\u2013450","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K","volume":"82","author":"D Zaridze","year":"1999","unstructured":"Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V (1999) Aspirin protects against gastric cancer: results of a case\u2013control study from Moscow, Russia. Int J Cancer 82:473\u2013476","journal-title":"Int J Cancer"},{"key":"33_CR52","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1054\/bjoc.2001.1702","volume":"84","author":"K Akre","year":"2001","unstructured":"Akre K, Ekstrom AM, Signorello LB, Hansson LE, Nyren O (2001) Aspirin and risk for gastric cancer: a population-based case\u2013control study in Sweden. Br J Cancer 84:965\u2013968","journal-title":"Br J Cancer"},{"key":"33_CR53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2458-2-18","volume":"2","author":"RJ Menezes","year":"2002","unstructured":"Menezes RJ, Huber KR, Mahoney MC, Moysich KB (2002) Regular use of aspirin and pancreatic cancer risk. BMC Public Health 2:18","journal-title":"BMC Public Health"},{"key":"33_CR54","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/jnci\/94.15.1168","volume":"94","author":"KE Anderson","year":"2002","unstructured":"Anderson KE, Johnson TW, Lazovich D, Folsom AR (2002) Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 94:1168\u20131171","journal-title":"J Natl Cancer Inst"},{"key":"33_CR55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jnci\/djh001","volume":"96","author":"ES Schernhammer","year":"2004","unstructured":"Schernhammer ES, Kang JH, Chan AT, et al (2004) A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst 96:22\u201328","journal-title":"J Natl Cancer Inst"},{"key":"33_CR56","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jnci\/djh084","volume":"96","author":"EJ Jacobs","year":"2004","unstructured":"Jacobs EJ, Connell CJ, Rodriguez C, Patel AV, Calle EE, Thun MJ (2004) Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst 96:524\u2013528","journal-title":"J Natl Cancer Inst"},{"key":"33_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","volume":"124","author":"DA Corley","year":"2003","unstructured":"Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124:47\u201356","journal-title":"Gastroenterology"},{"key":"33_CR57","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jnci\/djg106","volume":"95","author":"WH Wang","year":"2003","unstructured":"Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC (2003) Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 95:1784\u20131791","journal-title":"J Natl Cancer Inst"},{"key":"33_CR59","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.bjc.6600820","volume":"88","author":"C Bosetti","year":"2003","unstructured":"Bosetti C, Talamini R, Franceschi S, Negri E, Garavello W, La Vecchia C (2003) Aspirin use and cancers of the upper aerodigestive tract. Br J Cancer 88:672\u2013674","journal-title":"Br J Cancer"},{"key":"33_CR60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2407-2-31","volume":"2","author":"KB Moysich","year":"2002","unstructured":"Moysich KB, Menezes RJ, Ronsani A, et al (2002) Regular aspirin use and lung cancer risk. BMC Cancer 2:31","journal-title":"BMC Cancer"},{"key":"33_CR61","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/cncr.11242","volume":"97","author":"JE Muscat","year":"2003","unstructured":"Muscat JE, Chen SQ, Richie JP Jr, et al (2003) Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. Cancer 97:1732\u20131736","journal-title":"Cancer"},{"key":"33_CR62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjc.6600370","volume":"87","author":"A Akhmedkhanov","year":"2002","unstructured":"Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig KL, Shore RE (2002) Aspirin and lung cancer in women. Br J Cancer 87:49\u201353","journal-title":"Br J Cancer"},{"key":"33_CR63","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.bjc.6601343","volume":"89","author":"CN Holick","year":"2003","unstructured":"Holick CN, Michaud DS, Leitzmann MF, Willett WC, Giovannucci E (2003) Aspirin use and lung cancer in men. Br J Cancer 89:1705\u20131708","journal-title":"Br J Cancer"},{"key":"33_CR64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","volume":"7","author":"RE Harris","year":"1996","unstructured":"Harris RE, Namboodiri KK, Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7:203\u2013205","journal-title":"Epidemiology"},{"key":"33_CR65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/pmed.1999.0518","volume":"29","author":"PF Coogan","year":"1999","unstructured":"Coogan PF, Rao SR, Rosenberg L, et al (1999) The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med 29:72\u201376","journal-title":"Prev Med"},{"key":"33_CR66","first-page":"1213","volume":"10","author":"M Cotterchio","year":"2001","unstructured":"Cotterchio M, Kreiger N, Sloan M, Steingart A (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:1213\u20131217","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR67","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF, et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291:2433\u20132440","journal-title":"JAMA"},{"key":"33_CR68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000084818","volume":"68","author":"H Swede","year":"2005","unstructured":"Swede H, Mirand AL, Menezes RJ, Moysich KB (2005) Association of regular aspirin use and breast cancer risk. Oncology 68:40\u201347","journal-title":"Oncology"},{"key":"33_CR69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/aje\/kwi182","volume":"162","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case\u2013control Surveillance Study revisited. Am J Epidemiol 162:165\u2013170","journal-title":"Am J Epidemiol"},{"key":"33_CR70","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/65.4.723","volume":"85","author":"GD Friedman","year":"1980","unstructured":"Friedman GD, Ury HK (1980) Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst 85:723\u2013733","journal-title":"J Natl Cancer Inst"},{"key":"33_CR71","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/jnci\/88.14.988","volume":"88","author":"KM Egan","year":"1996","unstructured":"Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88:988\u2013993","journal-title":"J Natl Cancer Inst"},{"key":"33_CR72","first-page":"71","volume":"6","author":"RE Harris","year":"1999","unstructured":"Harris RE, Kasbari S, Farrar WB (1999) Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 6:71\u201373","journal-title":"Oncol Rep"},{"key":"33_CR73","first-page":"1586","volume":"11","author":"TW Johnson","year":"2002","unstructured":"Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev 11:1586\u20131591","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR74","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE, Chlebowski RT, Jackson RD, et al. (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women\u2019s Health Initiative. Cancer Res 63:6096\u20136101","journal-title":"Cancer Res"},{"key":"33_CR75","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bjc.6602003","volume":"91","author":"LA Garc\u00eda Rodr\u00edguez","year":"2004","unstructured":"Garc\u00eda Rodr\u00edguez LA, Gonz\u00e1lez P\u00e9rez A (2004) Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 91:525\u2013529","journal-title":"Br J Cancer"},{"key":"33_CR76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1055-9965.EPI-05-0472","volume":"14","author":"EJ Jacobs","year":"2005","unstructured":"Jacobs EJ, Thun MJ, Connell CJ, et al (2005) Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 14:261\u2013264","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR77","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H, et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97:805\u2013812","journal-title":"J Natl Cancer Inst"},{"key":"33_CR78","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ijc.2910550313","volume":"55","author":"A Tzonou","year":"1993","unstructured":"Tzonou A, Polychronopoulou A, Hsieh CC, Rebelakos A, Karakatsani A, Trichopoulos D (1993) Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer. Int J Cancer 55:408\u2013410","journal-title":"Int J Cancer"},{"key":"33_CR79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(97)08064-1","volume":"351","author":"DW Cramer","year":"1998","unstructured":"Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER (1998) Over-the-counter analgesics and risk of ovarian cancer. Lancet 351:104\u2013107","journal-title":"Lancet"},{"key":"33_CR80","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1023\/A:1008373616424","volume":"11","author":"A Tavani","year":"2000","unstructured":"Tavani A, Gallus S, La Vecchia C, Conti E, Montella M, Franceschi S (2000) Aspirin and ovarian cancer: an Italian case\u2013control study. Ann Oncol 11:1171\u20131173","journal-title":"Ann Oncol"},{"key":"33_CR81","first-page":"933","volume":"9","author":"L Rosenberg","year":"2000","unstructured":"Rosenberg L, Palmer JR, Rao RS, et al (2000) A case\u2013control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9:933\u2013937","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR82","first-page":"903","volume":"10","author":"KB Moysich","year":"2001","unstructured":"Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H (2001) Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 10:903\u2013906","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR83","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/pmed.2001.0945","volume":"33","author":"A Akhmedkhanov","year":"2001","unstructured":"Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Kato I, Koenig KL, Shore RE (2001) Aspirin and epithelial ovarian cancer. Prev Med 33:682\u2013687","journal-title":"Prev Med"},{"key":"33_CR84","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/A:1016380917625","volume":"13","author":"KM Fairfield","year":"2002","unstructured":"Fairfield KM, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE (2002) Aspirin, other NSAIDs, and ovarian cancer risk (United States). Cancer Causes Control 13:535\u2013342","journal-title":"Cancer Causes Control"},{"key":"33_CR85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.11538","volume":"108","author":"JV Lacey Jr","year":"2004","unstructured":"Lacey JV Jr, Sherman ME, Hartge P, Schatzkin A, Schairer C (2004) Medication use and risk of ovarian carcinoma: a prospective study. Int J Cancer 108:281\u2013286","journal-title":"Int J Cancer"},{"key":"33_CR86","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","volume":"84","author":"SA Khuder","year":"2001","unstructured":"Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84:1188\u20131192","journal-title":"Br J Cancer"},{"key":"33_CR87","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","volume":"349","author":"PE Goss","year":"2003","unstructured":"Goss PE, Ingle JN, Martino S, et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793\u20131802","journal-title":"N Engl J Med"},{"key":"33_CR88","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","volume":"91","author":"RB Ness","year":"1999","unstructured":"Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459\u20131467","journal-title":"J Natl Cancer Inst"},{"key":"33_CR89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:359\u2013345","journal-title":"Lancet"},{"key":"33_CR90","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X","volume":"77","author":"AE Norrish","year":"1998","unstructured":"Norrish AE, Jackson RT, McRae CU (1998) Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer 77:511\u2013515","journal-title":"Int J Cancer"},{"key":"33_CR91","unstructured":"Menezes RJ, Swede H, Mettlin C, Moysich KB (2002) Regular aspirin use and risk of prostate cancer. Proceedings of the American association for cancer research annual meeting. San Francisco, USA 43:933"},{"key":"33_CR92","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0022-5347(05)64277-2","volume":"168","author":"J Irani","year":"2002","unstructured":"Irani J, Ravery V, Pariente JL, et al (2002) Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol 168:1985\u20131988","journal-title":"J Urol"},{"key":"33_CR93","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.cej.0000180665.04335.de","volume":"15","author":"C Bosetti","year":"2006","unstructured":"Bosetti C, Talamini R, Negri E, Franceschi S, Montella M, La Vecchia C (2006) Aspirin and the risk of prostate cancer. Eur J Cancer Prev 15:43\u201345","journal-title":"Eur J Cancer Prev"},{"key":"33_CR94","first-page":"1108","volume":"11","author":"MF Leitzmann","year":"2002","unstructured":"Leitzmann MF, Stampfer MJ, Ma J, et al (2002) Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 11:1108\u20131111","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR95","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1015788502099","volume":"13","author":"LA Habel","year":"2002","unstructured":"Habel LA, Zhao W, Stanford JL (2002) Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control 13:427\u2013434","journal-title":"Cancer Causes Control"},{"key":"33_CR96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ijc.11250","volume":"106","author":"L Perron","year":"2003","unstructured":"Perron L, Bairati I, Moore L, Meyer F (2003) Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer 106:409\u2013415","journal-title":"Int J Cancer"},{"key":"33_CR97","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.649.13.4","volume":"13","author":"LA Garc\u00eda Rodr\u00edguez","year":"2004","unstructured":"Garc\u00eda Rodr\u00edguez LA, Gonz\u00e1lez P\u00e9rez A (2004) Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev 13:649\u2013653","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR98","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1158\/1055-9965.EPI-04-0532","volume":"14","author":"EA Platz","year":"2005","unstructured":"Platz EA, Rohrmann S, Pearson JD, et al (2005) Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging. Cancer Epidemiol Biomarkers Prev 14:390\u2013396","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR99","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/dji173","volume":"97","author":"EJ Jacobs","year":"2005","unstructured":"Jacobs EJ, Rodriguez C, Mondul AM, et al (2005) A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J Natl Cancer Inst 97:975\u2013980","journal-title":"J Natl Cancer Inst"},{"key":"33_CR100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.bjc.6601416","volume":"90","author":"S Mahmud","year":"2004","unstructured":"Mahmud S, Franco E, Aprikian A (2004) Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. Br J Cancer 90:93\u201399","journal-title":"Br J Cancer"},{"key":"33_CR101","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1054\/bjoc.1999.1106","volume":"82","author":"JE Castelao","year":"2000","unstructured":"Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK (2000) Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 82:1364\u20131369","journal-title":"Br J Cancer"},{"key":"33_CR102","first-page":"217","volume":"69","author":"JK McLaughlin","year":"1985","unstructured":"McLaughlin JK, Blot WJ, Mehl ES, Fraumeni JF (1985) Relation of analgesic use to renal cancer: population-based findings. Natl Cancer Inst Monogr 69:217\u2013222","journal-title":"Natl Cancer Inst Monogr"},{"key":"33_CR103","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910420104","volume":"42","author":"M McCredie","year":"1988","unstructured":"McCredie M, Ford JM, Stewart JH (1988) Risk factors for cancer of the renal parenchyma. Int J Cancer 42:13\u201316","journal-title":"Int J Cancer"},{"key":"33_CR104","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ije\/23.5.923","volume":"23","author":"A Mellemgaard","year":"1994","unstructured":"Mellemgaard A, Niwa S, Mehl ES, Engholm G, McLaughlin JK, Olsen JH (1994) Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 23:923\u2013930","journal-title":"Int J Epidemiol"},{"key":"33_CR105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.2910600312","volume":"60","author":"M McCredie","year":"1995","unstructured":"McCredie M, Pommer W, McLaughlin JK, et al (1995) International renal-cell cancer study. II. Analgesics. Int J Cancer 60:345\u2013349","journal-title":"Int J Cancer"},{"key":"33_CR106","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bjc.6690728","volume":"81","author":"M Gago-Dominguez","year":"1999","unstructured":"Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC (1999) Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer 81:542\u2013548","journal-title":"Br J Cancer"},{"key":"33_CR107","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1987) IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: an updating of IARC monographs, vols 1 to 42. Suppl. 7. International Agency for Research on Cancer, Lyon"},{"key":"33_CR108","first-page":"5510s","volume":"52","author":"L Bernstein","year":"1992","unstructured":"Bernstein L, Ross RK (1992) Prior medication use and health history as risk factors for non-Hodgkin\u2019s lymphoma: preliminary results from a case\u2013control study in Los Angeles County. Cancer Res 52:5510s\u20135515s","journal-title":"Cancer Res"},{"key":"33_CR109","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1021953224822","volume":"13","author":"I Kato","year":"2002","unstructured":"Kato I, Koenig KL, Shore RE, et al (2002) Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin\u2019s lymphoma (NHL) (United States). Cancer Causes Control 13:965\u2013974","journal-title":"Cancer Causes Control"},{"key":"33_CR110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/B:CACO.0000027506.55846.5d","volume":"15","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Holford TR, Leaderer B, et al (2004) Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 15:419\u2013428","journal-title":"Cancer Causes Control"},{"key":"33_CR111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jnci\/djh038","volume":"96","author":"ET Chang","year":"2004","unstructured":"Chang ET, Zheng T, Weir EG, et al (2004) Aspirin and the risk of Hodgkin\u2019s lymphoma in a population-based case\u2013control study. J Natl Cancer Inst 96:305\u2013315","journal-title":"J Natl Cancer Inst"},{"key":"33_CR112","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10552-004-3074-9","volume":"16","author":"JA Baker","year":"2005","unstructured":"Baker JA, Weiss JR, Czuczman MS, Menezes RJ, Ambrosone CB, Moysich KB (2005) Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 16:301\u2013308","journal-title":"Cancer Causes Control"},{"key":"33_CR113","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ijc.11311","volume":"106","author":"JR Cerhan","year":"2003","unstructured":"Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM (2003) Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer 106:784\u2013788","journal-title":"Int J Cancer"},{"key":"33_CR114","first-page":"534","volume":"12","author":"CM Kasum","year":"2003","unstructured":"Kasum CM, Blair CK, Folsom AR, Ross JA (2003) Non-steroidal anti-inflammatory drug use and risk of adult leukemia. Cancer Epidemiol Biomarkers Prev 12:534\u2013537","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"33_CR115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/JLongTermEffMedImplants.v13.i1.70","volume":"13","author":"LB Signorello","year":"2003","unstructured":"Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sorensen HT, Blot WJ (2003) Confounding by indication: implications for implant research. J Long Term Eff Med Implants 13:63\u201368","journal-title":"J Long Term Eff Med Implants"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-006-0033-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-006-0033-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-006-0033-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T09:10:02Z","timestamp":1707124202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-006-0033-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":115,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s10552-006-0033-7","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}